Art

J-GLOBAL ID：201902261404087994   Reference number：19A0610693

CISH is a negative regulator of IL-13-induced CCL26 production in lung fibroblasts

CISHは肺線維芽細胞におけるIL-13誘導CCL26産生の負の調節因子である

Author (17)： Takeshima Hideyuki (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Horie Masafumi (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Horie Masafumi (Division for Health Service Promotion, The University of Tokyo) ,  Horie Masafumi (Division of Pulmonary, Critical Care and Sleep Medicine and Hastings Center for Pulmonary Research, Department of Medicine, and Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California) ,  Mikami Yu (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Mikami Yu (Department of Clinical Laboratory Medicine, The University of Tokyo Hospital) ,  Makita Kosuke (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Miyashita Naoya (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Matsuzaki Hirotaka (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Noguchi Satoshi (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Urushiyama Hirokazu (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Hiraishi Yoshihisa (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Mitani Akihisa (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Mitani Akihisa (Division for Health Service Promotion, The University of Tokyo) ,  Borok Zea (Division of Pulmonary, Critical Care and Sleep Medicine and Hastings Center for Pulmonary Research, Department of Medicine, and Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California) ,  Nagase Takahide (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo) ,  Yamauchi Yasuhiro (Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo)
Material： Allergology International  (Allergol Int)
Volume： 68  Issue： 1  Page： 101-109(J-STAGE)  Publication year： 2019 
JST Material Number： L6446A  ISSN： 1323-8930  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *bronchial asthma ,...
Semi thesaurus term： cellular signal transduction ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0610693&from=J-GLOBAL&jstjournalNo=L6446A") }}

Author keywords (10)： Asthma ,  Eotaxin-3 ,  Fibroblast ,  Interleukin-13 ,  Transcriptome ,  Asthma ,  Eotaxin-3 ,  Fibroblast ,  Interleukin-13 ,  Transcriptome

JST classification (2)： Basic medicine on respiratory system  (GI01020H) ,  Immunologic diseases,allergic diseases in general.  (GD04010C)

Reference (47)：

• 1. Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol 2015;135:896-902.
• 2. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43:343-73.
• 3. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003;167:1360-8.
• 4. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012;180:1340-55.
• 5. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004;202:175-90.

Terms in the title (6)： CISH ,  肺線維芽細胞 ,  IL-13 ,  誘導 ,  CCL26 ,  調節因子